预测肝毒性模型辅助肝细胞癌质子与光子治疗的个体化选择
本研究开发并外部验证了一种基于全剂量体积直方图和临床因素的肝细胞癌放疗后肝毒性预测模型,可整合光子和质子剂量分布。模型在外部验证中受试者工作特征曲线下面积为0.78,优于基准模型,并补充美国放射肿瘤学会临床实践指南,可能支持质子治疗在肝细胞癌管理中的价值驱动整合。
要点
- 模型基于全剂量体积直方图和基线肝脏指标,可整合光子和质子治疗队列。
- 外部验证中模型受试者工作特征曲线下面积为0.78,优于基准模型的0.55至0.70。
- 激活图方法显示低剂量浴与基线肝功能低下交互作用的重要性。
核心结论
- 研究开发并外部验证了基于全剂量体积直方图和临床因素的肝细胞癌肝毒性个体化预测模型,可整合光子和质子治疗队列。
- 该模型补充美国放射肿瘤学会临床实践指南,可能支持质子治疗在肝细胞癌管理中的价值驱动整合。
研究设计与样本
- 训练数据为2008年至2019年本机构所有接受治疗的肝细胞癌患者(n=117,光子/质子为60%/40%)。
- 开发浅层卷积神经网络从剂量体积直方图和基线肝脏指标预测治疗后肝功能障碍,采用集成学习减少偏倚。
- 按预注册研究分析计划,用内部自助重采样评估稳定性,用不同机构数据集(n=88)评估泛化性。
- 实施类激活图方法表征关键剂量体积直方图子区域,并与逻辑回归和XGBoost基准比较。
主要发现
- 集成卷积神经网络模型内部性能与稳健性与基准相似。
- 外部验证中集成卷积神经网络模型受试者工作特征曲线下面积为0.78,基准模型为0.55至0.70。
- 外部验证中集成卷积神经网络模型精确率-召回率曲线下面积为0.6,基准模型为0.43至0.52。
- 模型在光子组预测能力改善,两种模态特异性均优,光子高风险组敏感性高。
- 仅基于剂量体积直方图构建的模型确认集成卷积神经网络模型更优,表明所提结构能有效从质子和光子剂量分布中提取特征。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our objective was to develop an externally validated model for predicting liver toxicity after radiation therapy in patients with hepatocellular carcinoma (HCC) that can integrate both photon and proton dose distributions with patient-specific characteristics. METHODS AND MATERIALS: Training data consisted of all patients with HCC treated between 2008 and 2019 at our institution (n = 117, 60%/40% photon/proton). We developed a shallow convolutional neural network (CNN) to predict posttreatment liver dysfunction from the differential dose-volume histogram (DVH) and baseline liver metrics. To reduce bias and improve robustness, we used ensemble learning (CNNE). After a preregistered study analysis plan, we evaluated stability using internal bootstrap resampling and generalizability using a data set from a different institution (n = 88). Finally, we implemented a class activation map method to characterize the critical DVH subregions and benchmarked the model against logistic regression and XGBoost. The models were evaluated using the area under the receiver operating characteristic curve and area under the precision-recall curve. RESULTS: The CNNE model showed similar internal performance and robustness compared with the benchmarks. CNNE exceeded the benchmark models in external validation, with an area under the receiver operating characteristic curve of 0.78 versus 0.55 to 0.70, and an area under the precision-recall curve of 0.6 versus 0.43 to 0.52. The model showed improved predictive power in the photon group, excellent specificity in both modalities, and high sensitivity in the photon high-risk group. Models built solely on DVHs confirm outperformance of the CNNE and indicate that the proposed structure efficiently abstracts features from both proton and photon dose distributions. The activation map method demonstrates the importance of the low-dose bath and its interaction with low liver function at baseline. CONCLUSIONS: We developed and externally validated a patient-specific prediction model for hepatic toxicity based on the entire DVH and clinical factors that can integrate both photon and proton therapy cohorts. This model complements the new American Society for Radiation Oncology clinical practice guidelines and could support value-driven integration of proton therapy into the management of HCC.
引用
- Chamseddine I, Kim Y, De B, et al. Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2023. PMID: 36739920. doi:10.1016/j.ijrobp.2023.01.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。